BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11781227)

  • 1. Multiple hematopoietic cell lineages develop in vivo from transplanted Pax5-deficient pre-B I-cell clones.
    Schaniel C; Bruno L; Melchers F; Rolink AG
    Blood; 2002 Jan; 99(2):472-8. PubMed ID: 11781227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
    Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
    Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clones.
    Schaniel C; Gottar M; Roosnek E; Melchers F; Rolink AG
    Blood; 2002 Apr; 99(8):2760-6. PubMed ID: 11929764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
    Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
    Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent.
    Ikawa T; Kawamoto H; Wright LY; Murre C
    Immunity; 2004 Mar; 20(3):349-60. PubMed ID: 15030778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5.
    Nutt SL; Heavey B; Rolink AG; Busslinger M
    Nature; 1999 Oct; 401(6753):556-62. PubMed ID: 10524622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors.
    Rolink AG; Nutt SL; Melchers F; Busslinger M
    Nature; 1999 Oct; 401(6753):603-6. PubMed ID: 10524629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development.
    Cotta CV; Zhang Z; Kim HG; Klug CA
    Blood; 2003 Jun; 101(11):4342-6. PubMed ID: 12560221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo.
    Vosshenrich CA; Ranson T; Samson SI; Corcuff E; Colucci F; Rosmaraki EE; Di Santo JP
    J Immunol; 2005 Feb; 174(3):1213-21. PubMed ID: 15661875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precursor B cells from Pax-5-deficient mice--stem cells for macrophages, granulocytes, osteoclasts, dendritic cells, natural killer cells, thymocytes and T cells.
    Rolink AG; Melchers F
    Curr Top Microbiol Immunol; 2000; 251():21-6. PubMed ID: 11036754
    [No Abstract]   [Full Text] [Related]  

  • 11. Stability and plasticity of wild-type and Pax5-deficient precursor B cells.
    Rolink AG; Schaniel C; Melchers F
    Immunol Rev; 2002 Sep; 187():87-95. PubMed ID: 12366685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoid precursors.
    Akashi K; Reya T; Dalma-Weiszhausz D; Weissman IL
    Curr Opin Immunol; 2000 Apr; 12(2):144-50. PubMed ID: 10712944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell potentials of early lymphoid and myeloid progenitors.
    Manz MG; Traver D; Miyamoto T; Weissman IL; Akashi K
    Blood; 2001 Jun; 97(11):3333-41. PubMed ID: 11369621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors.
    Höflinger S; Kesavan K; Fuxa M; Hutter C; Heavey B; Radtke F; Busslinger M
    J Immunol; 2004 Sep; 173(6):3935-44. PubMed ID: 15356142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages.
    Hodawadekar S; Yu D; Cozma D; Freedman B; Sunyer O; Atchison ML; Thomas-Tikhonenko A
    Exp Cell Res; 2007 Jan; 313(2):331-40. PubMed ID: 17098231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversion of B cell commitment upon loss of Pax5 expression.
    Mikkola I; Heavey B; Horcher M; Busslinger M
    Science; 2002 Jul; 297(5578):110-3. PubMed ID: 12098702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.
    McKenna HJ; Stocking KL; Miller RE; Brasel K; De Smedt T; Maraskovsky E; Maliszewski CR; Lynch DH; Smith J; Pulendran B; Roux ER; Teepe M; Lyman SD; Peschon JJ
    Blood; 2000 Jun; 95(11):3489-97. PubMed ID: 10828034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.
    Heavey B; Charalambous C; Cobaleda C; Busslinger M
    EMBO J; 2003 Aug; 22(15):3887-97. PubMed ID: 12881423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells.
    Taki S; Nakajima S; Ichikawa E; Saito T; Hida S
    J Immunol; 2005 May; 174(10):6005-12. PubMed ID: 15879093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage commitment in lymphopoiesis.
    Busslinger M; Nutt SL; Rolink AG
    Curr Opin Immunol; 2000 Apr; 12(2):151-8. PubMed ID: 10712946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.